Something is holding down the stock price and the company has been relatively quiet. The year end close is disappointing compared with the $28 high of the year.
Unfortunately Trump’s promises to address opioid crisis were all talk and no action. He hasn’t adopted any of the recommendations yet. Meanwhile the number of overdose deaths keep rising at exponential rates.
News 
Market Data 
Discover 
